| __timestamp | Dr. Reddy's Laboratories Limited | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 660772000 |
| Thursday, January 1, 2015 | 42585000000 | 736435000 |
| Friday, January 1, 2016 | 45702000000 | 775266000 |
| Sunday, January 1, 2017 | 46372000000 | 860348000 |
| Monday, January 1, 2018 | 46910000000 | 814775000 |
| Tuesday, January 1, 2019 | 48890000000 | 942821000 |
| Wednesday, January 1, 2020 | 50129000000 | 985616000 |
| Friday, January 1, 2021 | 54559000000 | 1061508000 |
| Saturday, January 1, 2022 | 62081000000 | 1190423000 |
| Sunday, January 1, 2023 | 105931000000 | 1254234000 |
| Monday, January 1, 2024 | 77201000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, understanding the financial strategies of industry giants is crucial. Dr. Reddy's Laboratories Limited and Grifols, S.A. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Dr. Reddy's Laboratories saw a remarkable 173% increase in SG&A expenses, peaking in 2023. This surge reflects their aggressive expansion and market penetration strategies. In contrast, Grifols, S.A. exhibited a more modest growth of approximately 90% in the same period, indicating a steady yet cautious approach to scaling operations. Notably, the data for 2024 is incomplete, highlighting the dynamic nature of financial reporting. These trends underscore the diverse strategies employed by pharmaceutical leaders to navigate global markets and optimize operational efficiencies.
Cost Management Insights: SG&A Expenses for Johnson & Johnson and Grifols, S.A.
Selling, General, and Administrative Costs: Sanofi vs Dr. Reddy's Laboratories Limited
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Intra-Cellular Therapies, Inc. and Dr. Reddy's Laboratories Limited: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Dr. Reddy's Laboratories Limited and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Evotec SE
Selling, General, and Administrative Costs: Grifols, S.A. vs Ultragenyx Pharmaceutical Inc.
Grifols, S.A. vs Bausch Health Companies Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Grifols, S.A. and Arrowhead Pharmaceuticals, Inc.
Comparing SG&A Expenses: Grifols, S.A. vs Travere Therapeutics, Inc. Trends and Insights